文献速递乳腺MR

基于预测模型降低极高密度乳腺女性筛查MRI假阳性率

Reducing False-Positive Screening MRI Rate in Women with Extremely Dense Breasts Using Prediction Models Based on Data from the DENSE Trial.
PubMed 文献 · Radiology · 2021-08-17

本研究基于DENSE随机对照试验数据,纳入454例首次补充MRI筛查阳性(BI-RADS 3/4/5)的极高密度乳腺女性,其中79例为真阳性(乳腺癌)、375例为假阳性。利用多变量逻辑回归构建预测模型,完整模型AUC为0.88,可在不漏诊任何癌症的前提下避免45.5%的假阳性召回和21.3%的良性活检;仅基于MRI表现和年龄的简化模型AUC为0.84,可避免35.5%的假阳性筛查结果和13.0%的良性活检。

要点

  • 极高密度乳腺女性补充MRI筛查阳性者中假阳性占比高(375/454),需预测模型辅助区分。
  • 基于临床特征和MRI表现的完整预测模型AUC达0.88,可避免45.5%假阳性召回且不漏诊癌症。
  • 仅用MRI表现和年龄的简化模型AUC为0.84,可避免35.5%假阳性筛查结果。

局限性

  • 本研究为DENSE试验的二次分析,预测模型基于特定人群(荷兰50-75岁、Volpara密度4类)首轮筛查数据,外推需验证。
  • 原文未报告模型在独立外部验证集中的表现。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background High breast density increases breast cancer risk and lowers mammographic sensitivity. Supplemental MRI screening improves cancer detection but increases the number of false-positive screenings. Thus, methods to distinguish true-positive MRI screening results from false-positive ones are needed. Purpose To build prediction models based on clinical characteristics and MRI findings to reduce the rate of false-positive screening MRI findings in women with extremely dense breasts. Materials and Methods Clinical characteristics and MRI findings in Dutch breast cancer screening participants (age range, 50-75 years) with positive first-round MRI screening results (Breast Imaging Reporting and Data System 3, 4, or 5) after a normal screening mammography with extremely dense breasts (Volpara density category 4) were prospectively collected within the randomized controlled Dense Tissue and Early Breast Neoplasm Screening (DENSE) trial from December 2011 through November 2015. In this secondary analysis, prediction models were built using multivariable logistic regression analysis to distinguish true-positive MRI screening findings from false-positive ones. Results Among 454 women (median age, 52 years; interquartile range, 50-57 years) with a positive MRI result in a first supplemental MRI screening round, 79 were diagnosed with breast cancer (true-positive findings), and 375 had false-positive MRI results. The full prediction model (area under the receiver operating characteristics curve [AUC], 0.88; 95% CI: 0.84, 0.92), based on all collected clinical characteristics and MRI findings, could have prevented 45.5% (95% CI: 39.6, 51.5) of false-positive recalls and 21.3% (95% CI: 15.7, 28.3) of benign biopsies without missing any cancers. The model solely based on readily available MRI findings and age had a comparable performance (AUC, 0.84; 95% CI: 0.79, 0.88; P = .15) and could have prevented 35.5% (95% CI: 30.4, 41.1) of false-positive MRI screening results and 13.0% (95% CI: 8.8, 18.6) of benign biopsies. Conclusion Prediction models based on clinical characteristics and MRI findings may be useful to reduce the false-positive first-round screening MRI rate and benign biopsy rate in women with extremely dense breasts. Clinical trial registration no. NCT01315015 © RSNA, 2021 Online supplemental material is available for this article. See also the editorial by Imbriaco in this issue.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. den Dekker BM, Bakker MF, de Lange SV, et al. Reducing False-Positive Screening MRI Rate in Women with Extremely Dense Breasts Using Prediction Models Based on Data from the DENSE Trial. Radiology. 2021. PMID: 34402665. doi:10.1148/radiol.2021210325

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。